MétaCan
Menu
Back to cohort

In Vivo Control of Acute Lymphoblastic Leukemia by Immunostimulatory CpG Oligonucleotides.

2006· article· en· W4240828665 on OpenAlexaff
Gregor S. D. Reid, Hisaki Fujii, Jacqueline D. Trudeau, Junior Hall, Jonathan D. Fish, David T. Teachey, Valerie I. Brown, Kirk R. Schultz, Stephan A. Grupp

Bibliographic record

VenueBlood · 2006
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicRNA Interference and Gene Delivery
Canadian institutionsBC Children's Hospital
Fundersnot available
KeywordsImmunologyMedicineCpG OligodeoxynucleotideImmune systemTransplantationSevere combined immunodeficiencyImmunotherapyBone marrowCancer researchIn vivoCancerLeukemiaCpG siteBiologyInternal medicineDNA methylation

Abstract

fetched live from OpenAlex

Abstract Acute lymphoblastic leukemia (ALL) is the most common childhood cancer. While current therapy is effective for the majority of children, relapsed ALL remains the fifth most common pediatric malignancy and responds very poorly to treatment. In addition, about 50% of ALL cases occur in adults, and while remission is achieved in many patients the majority of these will succumb to relapsed disease. In most cases relapse is treated with more intensive chemotherapy or hematopoietic cell transplantation, therapies that are associated with significant toxicity. In both patient populations, therefore, there is an urgent need for novel approaches to inhibit disease progression. Immunostimulatory DNA oligonucleotides containing CpG motifs (CpG ODN) have been shown to induce strong anti-tumor immune activity in a variety of model systems and are currently being evaluated in clinical trials. We have previously reported that CpG ODN stimulation of ALL cells alters their antigen presentation ability and enhances Th1 responses by allogeneic T cells. In this study, using NOD-SCID mice bearing xenografts of primary human ALL or human ALL cell lines, we demonstrate that CpG ODN stimulate significant immune activity against ALL cells in vivo. A single intravenous injection of 300micrograms Class B CpG ODN induced a significant reduction in percentage of human ALL cells in peripheral blood (P<0.0001), spleen (P=0.0036) and liver (P=0.0004), but not bone marrow (P=0.254), compared to PBS treatment of mice. The reduced leukemia burden in the spleens of CpG ODN treated mice correlated with a significantly higher percentage of Annexin-V positive ALL cells (P=0.008 for PBS vs CpG; P=0.016 for CpG vs control ODN), indicating the induction of leukemia cell death in these mice. In addition, repeated administration of CpG ODN mediated continued disease control, and significantly improved survival of mice with established primary sample or cell line derived human ALL (P=0.002). The death of leukemia cells in vivo was independent of the ability of ALL cells to respond directly to CpG ODN, and correlated with the production of significant amounts of interferon-alpha, interferon-gamma and IL-12 in treated mice. Cell depletion studies implicate natural killer cells in the CpG ODN induced killing of human ALL. Preliminary results obtained using the Emu-ret transgenic mouse model of B cell leukemia indicate that CpG ODN treatment also induces killing of syngeneic leukemia cells, and work is ongoing to identify the immune mechanisms mediating this activity. Based on these results, we hypothesize that CpG ODN will have considerable potential as a novel agent for the prevention of ALL progression.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.001
Threshold uncertainty score0.004

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.003
GPT teacher head0.197
Teacher spread0.195 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations3
Published2006
Admission routes1
Has abstractyes

Explore more

Same venueBloodSame topicRNA Interference and Gene DeliveryFrench-language works237,207